Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.3651
+0.01544.40%
Post-market: 0.36920.0041+1.12%19:54 EDT
Volume:1.20M
Turnover:431.88K
Market Cap:12.12M
PE:-0.14
High:0.3841
Open:0.3498
Low:0.3315
Close:0.3497
Loading ...
Oct 21, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 17, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 17, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 13, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 22, 2022

Major Issues Report

8-K - Current report
Sep 20, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 01, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2022

Major Issues Report

8-K - Current report
Mar 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2022

Major Issues Report

8-K - Current report
Mar 07, 2022

Major Issues Report

8-K - Current report
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 20, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals